Cancer Biology & Genetics Program

The Scott Lowe Lab

Scott W. Lowe, PhD

Chair, Cancer Biology & Genetics Program, SKI; Chair, Geoffrey Beene Cancer Research Center; Investigator, Howard Hughes Medical Institute

About the Scott Lowe Lab

Our laboratory studies tumor-suppressor networks controlling apoptosis and senescence and how their disruption influences malignant behavior.

Follow Lowe Lab on Twitter!

View Lab Overview

Research Projects

VIDEO | 02:17

Inside My Lab: Scott Lowe

Go inside the lab of Scott Lowe from SKI’s Cancer Biology & Genetics Program.

Video Details

Featured News

Sloan Kettering Institute Scientists Learn How Genes and Environment Conspire in Pancreatic Cancer Development

Wednesday, February 3, 2021

The insights lay the groundwork for earlier diagnosis and better treatment of the disease.

Confronting a Crisis: How MSK Cancer Geneticists Responded to COVID-19

Friday, January 8, 2021

During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.

In the Lab

Fluorescent image of CAR T cells in mouse liver fibrosis

A New Target for CAR T Cells: Senescence-Related Diseases

Wednesday, June 17, 2020

From atherosclerosis and diabetes to liver fibrosis and osteoarthritis, senescent cells are at the root of many debilitating diseases. Scientists increasingly have them in the crosshairs.

View All Featured News

Publications

Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis.

Burdziak C, Alonso-Curbelo D, Walle T, Reyes J, Barriga FM, Haviv D, Xie Y, Zhao Z, Zhao CJ, Chen HA, Chaudhary O, Masilionis I, Choo ZN, Gao V, Luan W, Wuest A, Ho YJ, Wei Y, Quail DF, Koche R, Mazutis L, Chaligné R, Nawy T, Lowe SW, Pe’er D.Science. 2023 May 12;380(6645):eadd5327. doi: 10.1126/science.add5327. Epub 2023 May 12.PMID: 37167403

Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity.

Chen HA, Ho YJ, Mezzadra R, Adrover JM, Smolkin R, Zhu C, Woess K, Bernstein N, Schmitt G, Fong L, Luan W, Wuest A, Tian S, Li X, Broderick C, Hendrickson RC, Egeblad M, Chen Z, Alonso-Curbelo D, Lowe SW.Cancer Discov. 2023 Feb 6;13(2):432-453. doi: 10.1158/2159-8290.CD-22-0528.PMID: 36302222 Free PMC article.

MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis.

View All Publications

People

Scott W. Lowe, PhD

Chair, Cancer Biology & Genetics Program, SKI; Chair, Geoffrey Beene Cancer Research Center; Investigator, Howard Hughes Medical Institute

Cancer biologist Scott Lowe uses genetically engineered mouse models to study how the genetic alterations in cancer cells contribute to tumorigenesis, alter treatment response, and create molecular vulnerabilities that may be targeted therapeutically.
PhD, Massachusetts Institute of Technology

[email protected]: Email Address
646-888-3342: Office Phone
Download CV: PDF File

Members

Valentin Barthet
Postdoctoral Researcher

Andrea Chaikovsky
Postdoctoral Researcher

Almudena Chaves Perez
Postdoctoral Researcher

Isabella Del Priore, BS — Isabella Del Priore
Graduate Student

Clemens Hinterleitner
Postdoctoral Researcher

Yu-Jui (Ray) Ho, PhD — Yu-Jui (Ray) Ho
Computational Biologist

Domhnall McHugh, PhD — Domhnall McHugh
Postdoctoral Researcher

Riccardo Mezzadra
Postdoctoral Researcher

Kaloyan Tsanov, PhD — Kaloyan Tsanov
Postdoctoral Researcher

Janelle Simon, BS — Janelle Simon
Mouse Colony Manager

Wei Luan, MD — Wei Luan
Senior Research Technician

Sha Tian, MS — Sha Tian
Senior Research Technician

Lynn Boss, MS — Lynn Boss
Administrative Coordinator

Lab Alumni

Direna Alonso Curbelo, PhD — Direna Alonso Curbelo
Junior Group Leader, Cancer Science, IRB Barcelona, Spain

Francisco Barriga, PhD — Francisco (Pancho) Barriga
Group Leader - Cancer Genome Engineering Lab Vall D´Hebron Institute of Oncology (VHIO)

Iris Appelmann, MD — Iris Appelmann
Physician, University Hospital RWTH Aachen, Germany

Corina Amor Vegas
CSHL Independent Fellow at Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

Ana Banito, PhD — Ana Banito
Group Leader, German Cancer Research Center (DKFZ), Heidelberg, Germany

Benedikt Bosbach, PhD — Benedikt Bosbach
Principal Scientist, CTI, Pfizer Research, New York

Chi-Chao Chen, MD — Chi-Chao Chen
Data Scientist, Agios Pharmaceuticals, Inc., Cambridge, MA

Hsuan-An Chen — Hsuan-An (Sean) Chen
Postdoctoral Fellow at Rockefeller University, New York, NY

Chong Chen, PhD — Chong Chen
Professor, Sichuan University, Sichuan, China

Lukas Dow, PhD — Lukas Dow
Assistant Professor, Weill Cornell Medical College, New York, NY

Saya Ebbesen, PhD — Saya Ebbesen
Director, Medical & Scientific Strategy, BluPrint Oncology, London

Katerina Hatzi, PhD — Katerina Hatzi
Senior Scientist, Oncology Biomarker Development, Genentech, San Francisco, CA

Shauna Houlihan, PhD — Shauna Houlihan
Associate Director, Liver Research, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY

Grace Xiang Li, MS — Xiang (Grace) Li
Postdoctoral Fellow, Harvard University, Cambridge, MA

Chun-Hao Huang, PhD — Chun-Hao Huang
Co-Founder & CEO, Algen Biotechnologies, San Francisco, CA

Edward Kastenhuber, PhD — Edward (Ted) Kastenhuber
Postdoctoral Associate, Weill Cornell Medicine, New York, NY

Thomas Kitzing, PhD — Thomas Kitzing
Senior Research Scientist, Philipps University of Marburg, Institute of Pharmacology, Germany

Josef Leibold, MD — Josef Leibold
Group Leader, University of Tübingen, Germany

Kiki Yu Liu, PhD — Yu (Kiki) Liu
Professor, Sichuan University, Sichuan, China

Geulah Livshits, PhD — Geulah Livshits
Senior Research Analyst, Biotechnology and Pharmaceuticals, Chardan Capital Markets LLC, New York, NY

Bryan Ngo
Group Leader, Altos Labs, San Francisco, CA

Stella Paffenholz, PhD — Stella Paffenholz
Analyst, Nexttech, Boston, MA

Francisco Sánchez-Rivera, PhD — Francisco J. Sánchez-Rivera
Assistant Professor of Biology, Massachusetts Institute of Technology, Cambridge, MA

Evangelia Loizou, PhD — Evangelia Loizou
Senior Research Associate, Intelligencia, New York, NY

Amaia Lujambio, PhD — Amaia Lujambio
Associate Professor, Mount Sinai School of Medicine, New York, NY

Eusebio Manchado Robles, PhD — Eusebio Manchado Robles
Senior Principal Scientist, Novartis, Basel, Switzerland

Allison Mayle, Postdoctoral Researcher — Allison Mayle
Assistant Director, DNALC, Cold Spring Harbor Laboratory, New York

Ozlem Mert, PhD — Özlem Aksoy (née Mert)
Senior Scientist, Pfizer, San Francisco, CA

Cornelius Miething, PhD — Cornelius Miething
Group Leader and Medical Fellow, University Medical Center Freiburg, Germany

John P. Morris IV, PhD — John P. Morris IV
Assistant Professor, Department of Pharmacology, University of North Carolina, Chapel Hill, NC

Kevin P. O'Rourke

Investments, Roivant Sciences, New York, NY

Cory Rillahan, MD, PhD — Cory Rillahan
Clinical Fellow, Pediatrics, Boston Children's Hospital, Boston, MA

Marcus Ruscetti, PhD — Marcus Ruscetti
Assistant Professor, Molecular, Cell & Cancer Biology, University of Massachusetts Medical School, Worcester, MA

Anna Saborowski, MD — Anna Saborowski
Physician, Hannover Medical School, Germany

Michael Saborowski, MD — Michael Saborowski
Physician, Hannover Medical School, Germany

Charles J Sherr — Charles J. Sherr
Chair, Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN

Nilgun Tasdemir, PhD — Nilgun Tasdemir
Senior Scientist, Functional Genomics, Target Sciences, Pfizer, New York, NY

Darjus Tschaharganeh, MD — Darjus Tschaharganeh
Group Leader, German Cancer Research Center (DKFZ), Heidelberg, Germany

Susann Weissmueller, PhD — Susann Weissmueller
Strategic Partnering Associate, Roche, Basel, Switzerland

Zhen Zhao, MD PhD — Zhen Zhao
Pathology Resident, The Mount Sinai Hospital, New York, NY

Sarah Ackermann
Research Specialist, Weill Cornell Medicine, New York, NY

James H. Ahn, MS — James H. Ahn
Research Technician

Erica Anderson, BS — Erica Anderson
Research Technician

Ho-Chung Chen, MS — Ho-Chung Chen
Research Technician

Jonathan Fisher, BS — Jonathan Fisher
Research Technician

Danielle Grace, BS — Danielle Grace
Research Technician

Fernanda Luna, BA — Fernanda Luna
Research Technician

Jamie Plevy, BSE MS — Jamie Plevy
Research Technician

Katarzyna Rybczyk — Katarzyna (Kasia) Rybczyk
Research Technician

Aditya S. Shroff, BS — Aditya S. Shroff
Research Technician

Meredith Taylor, BS — Meredith Taylor
Research Technician

Leah Zamechek, MS — Leah Zamechek
Laboratory Manager

Lab Affiliations

Lab News & Events

Tweets by @https://twitter.com/LoweLabMSKCC

Get in Touch

[email protected]

Lab Head Email
646-888-3342

Office Phone
646-888-3347

Office Fax
646-888-3340

Lab Phone
Lowe Lab Twitter

Lab Resources

Scott Lowe Lab Plasmid and Animal Requests

Request plasmids through Addgene More »

For plasmids not listed on Addgene, please contact our Lab Manager, Anne Trumble-Koncelik, [email protected].

For animal requests, please contact our Mouse Colony Manager, Janelle Simon, [email protected].

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Scott W. Lowe discloses the following relationships and financial interests:

Blueprint Medicines
Equity; Professional Services and Activities
Eli Lilly and Company
Equity
Faeth Therapeutics, Inc
Equity; Professional Services and Activities (Uncompensated)
Fate Therapeutics
Intellectual Property Rights; Professional Services and Activities
Geras Bio Inc
Equity; Professional Services and Activities (Uncompensated)

Mirimus
Equity; Professional Services and Activities
Oric Pharmaceuticals
Equity; Professional Services and Activities
PMV Pharma
Equity; Professional Services and Activities
Senescea Therapeutics
Equity; Intellectual Property Rights; Professional Services and Activities (Uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures